MAPK3 and colitis: We previously demonstrated that daily administration of Ang 1–7 significantly decreased colitis severity at both gross and histological levels, which was mediated, in part, by decreased colonic expression/activity of various pro-inflammatory proteins, such as ERK1/2, p38 MAPK, Akt, and Ang II [5].